Institution · Advanced Cancer Therapeutics
Most cited papers from Advanced Cancer Therapeutics
What are the most cited papers from Advanced Cancer Therapeutics?
The most cited paper from Advanced Cancer Therapeutics is "Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer" (Navneet Kaur Dhillon, Bharat Bhushan Aggarwal, Robert Alan Newman et al., 2008), with 1,333 citations. Next come "Autophagy as a target for anticancer therapy" (816) and "Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells" (511).
Showing 50 of 59 papers. Every paper with more than 53 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer Navneet Kaur Dhillon, Bharat Bhushan Aggarwal, Robert Alan Newman et al. · Clinical Cancer Research | 15 Jul 2008 | 1,333 |
| 2 | Autophagy as a target for anticancer therapy Filip Jankú, David James McConkey, David S. Hong et al. · Nature Reviews Clinical Oncology | 17 May 2011 | 816 |
| 3 | Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Kip A. West, John Brognard, Amy Sanders Clark et al. · Journal of Clinical Investigation | 2003 | 511 |
| 4 | Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Michael G. Sun, Zeev E. Estrov, Yuan Ji et al. · Molecular Cancer Therapeutics | Mar 2008 | 412 |
| 5 | Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results Alex Y. C. Chang, K. Kim, John H. Glick et al. · JNCI Journal of the National Cancer Institute | 3 Mar 1993 | 339 |
| 6 | The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells Yiling Lu, Yue-Zhen Lin, Ruth LaPushin et al. · Oncogene | 25 Nov 1999 | 338 |
| 7 | Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer Scott Michael Lippman, J. J. Lee, Daniel D. Karp et al. · JNCI Journal of the National Cancer Institute | 18 Apr 2001 | 321 |
| 8 | Eye Injuries Associated with Anesthesia A Closed Claims Analysis William M. Gild, Karen L. Posner, Robert A. Caplan et al. · Anesthesiology | Feb 1992 | 291 |
| 9 | Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer Brian F. Clem, Julie O’Neal, Gilles H. Tapolsky et al. · Molecular Cancer Therapeutics | 15 May 2013 | 279 |
| 10 | Richter syndrome Apostolia Maria Tsimberidou, Michael J. Keating · Cancer | Dec 2004 | 276 |
| 11 | Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment Maria Pia Morelli, Michael James Overman, Arvind N. Dasari et al. · Annals of Oncology | 28 Jan 2015 | 256 |
| 12 | Targeted therapy in non-small-cell lung cancer—is it becoming a reality? Filip Jankú, David J. Stewart, Razelle Kurzrock · Nature Reviews Clinical Oncology | 15 Jun 2010 | 251 |
| 13 | Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin Edward A. Sausville, Joseph E. Tomaszewski, Percy S. Ivy · Current Cancer Drug Targets | Oct 2003 | 226 |
| 14 | PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers Filip Jankú, J. Jack Lee, Apostolia Maria Tsimberidou et al. · PLoS ONE | 29 Jul 2011 | 204 |
| 15 | Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293 Avi I. Einzig, Donna S Neuberg, Scot C. Remick et al. · Medical Oncology | Jun 1996 | 197 |
| 16 | Differentiation patterns in the blastic phase of chronic myeloid leukemia. James D. Griffin, Robert F. Todd, Jerome Ritz et al. · PubMed | 1983 | 196 |
| 17 | A Novel, Macrophage Migration Inhibitory Factor Suicide Substrate Inhibits Motility and Growth of Lung Cancer Cells Millicent G. Winner, Jason B. Meier, Swen Zierow et al. · Cancer Research | 14 Sep 2008 | 168 |
| 18 | Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers Fadi Braiteh, Andres O. Soriano, Guillermo Garcia‐Manero et al. · Clinical Cancer Research | 30 Sep 2008 | 166 |
| 19 | The Dose Response of Caudal Morphine in Children Elliot J. Krane, Donald C. Tyler, Lawrence Jacobson · Anesthesiology | Jul 1989 | 158 |
| 20 | Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers Susmita Mondal, Debarshi Roy, Sayantani Sarkar Bhattacharya et al. · International Journal of Cancer | 18 Sep 2018 | 156 |
| 21 | Effect of Equiosmolar Solutions of Mannitol versus Hypertonic Saline on Intraoperative Brain Relaxation and Electrolyte Balance Irene Rozet, Nuj Tontisirin, Saipin L. Muangman et al. · Anesthesiology | Nov 2007 | 151 |
| 22 | Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy Sherene Loi · OncoImmunology | Jul 2013 | 146 |
| 23 | Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial A H Sarris, Frederick B. Hagemeister, Jorge Enrique Romaguera et al. · Annals of Oncology | 2000 | 143 |
| 24 | Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopenia Mark J. Bishton, Simon James Harrison, Benjamin P. Martin et al. · Blood | 4 Feb 2011 | 139 |
| 25 | Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial David R. Gandara, Everett E. Vokes, Mark A. Green et al. · Journal of Clinical Oncology | 2000 | 135 |
| 26 | Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma Shatha AbuHammad et al. · Proceedings of the National Academy of Sciences | 22 Aug 2019 | 129 |
| 27 | Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies Ailsa J. Christiansen, Alison C. West, Kellie-Marie Banks et al. · Proceedings of the National Academy of Sciences | 22 Feb 2011 | 116 |
| 28 | Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1) Yasumasa Honjo, Kuniaki Morisaki, Lyn Mickley Huff et al. · Cancer Biology & Therapy | Nov 2002 | 116 |
| 29 | The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy Constantine Si Lun Tam, Susan Mary O'Brien, Susan A. Lerner et al. · Leukemia & lymphoma/Leukemia and lymphoma | 2007 | 98 |
| 30 | Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service Henrique Afonseca Parsons, Vickie Elaine Baracos, Navjot Dhillon et al. · PLoS ONE | 3 Jan 2012 | 97 |
| 31 | Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma Ahmed Omar Kaseb, Mohamed Shama, İbrahim Halil Şahin et al. · Oncology | 2013 | 96 |
| 32 | BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes Hazem Edmond El-Osta, Gerald Steven Falchook, Apostolia Maria Tsimberidou et al. · PLoS ONE | 19 Oct 2011 | 94 |
| 33 | Safety of Chronic Intrathecal Morphine Infusion in a Sheep Model Tamara Lee Gradert, Wallace B. Baze, William C. Satterfield et al. · Anesthesiology | Jul 2003 | 89 |
| 34 | Immunoneutralization of gonadotropin-releasing hormone type-III suppresses male reproductive behavior of cichlids Satoshi Ogawa, Go Akiyama, Shumei Kato et al. · Neuroscience Letters | 20 Jun 2006 | 88 |
| 35 | The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer Jayoung Kim, Wun‐Jae Kim, Zhiqian Liu et al. · Cell Cycle | 15 Mar 2012 | 87 |
| 36 | The anticancer effects of HDAC inhibitors require the immune system Alison C. West, Mark John Smyth, Ricky W. Johnstone · OncoImmunology | 2014 | 87 |
| 37 | RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma Elizabeth Gardner Grubbs, Patrick Kwok‐Shing Ng, Jacquelin H. Bui et al. · The Journal of Clinical Endocrinology & Metabolism | 29 Dec 2014 | 83 |
| 38 | Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies David S. Hong, Saı̈d M. Sebti, Robert Alan Newman et al. · Clinical Cancer Research | 11 Nov 2009 | 81 |
| 39 | Richter’s Transformation in Chronic Lymphocytic Leukemia Apostolia Maria Tsimberidou, Michael J. Keating · Seminars in Oncology | Apr 2006 | 79 |
| 40 | Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells Jayoung Kim, Samantha Morley, Minh T. N. Le et al. · Cancer Biology & Therapy | 14 Jan 2014 | 79 |
| 41 | Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies Apostolia Maria Tsimberidou, Yesid Alvarado, Francis Joseph Giles · Expert Review of Anticancer Therapy | Aug 2002 | 77 |
| 42 | Microbial contamination of hematopoietic progenitor cell grafts—incidence, clinical outcome, and cost‐effectiveness: an analysis of 735 grafts Rammurti T. Kamble, Shubham Pant, George Basil Selby et al. · Transfusion | 31 May 2005 | 75 |
| 43 | Survival of patients in a Phase 1 clinic Jennifer J. Wheler, Apostolia Maria Tsimberidou, David S. Hong et al. · Cancer | 22 Jan 2009 | 75 |
| 44 | C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression Vikas Bhardwaj, Yanai Zhan, María Angélica Cortez et al. · Journal of Thoracic Oncology | 22 May 2012 | 73 |
| 45 | β1 integrin Grant A. Howe, Christina Addison · Cell Adhesion & Migration | Mar 2012 | 68 |
| 46 | Pediatric Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia Dolly G. Aguilera, Christos Vaklavas, Apostolia Maria Tsimberidou et al. · Journal of Pediatric Hematology/Oncology | 29 Oct 2009 | 64 |
| 47 | Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma Andreas M. F. Heilmann et al. · Oncology | 2016 | 63 |
| 48 | An Association Between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus Theodore G. Krontiris, Bernie Devlin, Daniel D. Karp · Diagnostic Molecular Pathology | Sep 1994 | 63 |
| 49 | Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma Lin Yang, H. Wang, Steven Mitchell Kornblau et al. · Oncogene | 8 Nov 2010 | 63 |
| 50 | Functional Differences Between Monocyte Chemotactic Protein-1 Receptor A and Monocyte Chemotactic Protein-1 Receptor B Expressed in a Jurkat T Cell Sheila K. Sanders, Sheila M. Crean, Peter A. Boxer et al. · The Journal of Immunology | Nov 2000 | 60 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.